Cuban drug Heberprot-P authorized for medical trials in the US - Prensa Latina

Retrieved on: 2024-05-04 15:40:56

Tags for this article:

Complications of diabetes

Foot diseases

Center for Genetic Engineering and Biotechnology

Pressure ulcer

Nepidermin

Total contact casting

Heberprot-P

u.s. food and drug administration

Click the tags to see associated articles and topics

Cuban drug Heberprot-P authorized for medical trials in the US - Prensa Latina. View article details on hiswai:

Summary

Heberprot-P, a drug developed by Cuba's CIGB, shows potential for healing diabetic foot ulcers and reducing amputations. Its phase-three trial is approved by the FDA, indicating significant advances in treatment options for diabetic complications.

Article found on: www.plenglish.com

View Original Article